Sign up now
 

CONNIE REYBROUCK gets the special treatment she needs for her heart.

  CONNIE'S STORY

 

ROY KING'S experiences at the Strong Heart Wellness & Prevention Program.

  ROY'S STORY

 

PAM VANWUYCKHUYSE has a heart attack on her wedding day.

  PAM'S STORY

 

DOUG CHILDS is cured of atrial fibrillation, and returns to basketball.

  DOUG'S STORY

 

TOM ARCARA is saved after a devastating heart attack.

  TOM A.'S STORY

 

ANNETTE LAWRENCE’S dangerously high blood pressure gets controlled.

  ANNETTE'S STORY

Increase type size
Decrease type size
 
 

Find a Doctor

Frederick S. Ling, M.D.

Dr. Ling

Dr. Ling is an Associate Professor of medicine in the Cardiology Unit and Director of the Cardiac Catheterization Laboratory. He joined the faculty in 1993 after training at Yale University in both cardiovascular medicine and interventional cardiology. Dr. Ling specializes in all aspects of interventional cardiology in the evaluation and treatment of coronary artery disease.

Under his direction, the Cardiac Catheterization Laboratory currently consists of four labs, but is undergoing expansion. All angiographic studies are now digitally archived and networked for immediate access and review. A computerized reporting system with a central database tracks patients for data collection and research. The Cardiac Catheterization Laboratory also has been at the core of Strong Memorial Hospital's successful clinical program to treat acute myocardial infarction by primary angioplasty or stenting.

 

To make an appointment, call 1-866-HEART-03

Research in the Cardiac Catheterization Laboratory takes many avenues. They include the assessment of new antithrombotic and antiplatelet agents such as the direct thrombin inhibitors and a number of antiplatelet glycoprotein IIb/IIIa receptor inhibitors in coronary intervention and acute coronary syndromes. Studies are also ongoing with new pharmaceuticals and monoclonal antibodies to prevent reperfusion injury after primary angioplasty of acute myocardial infarction. There is also active research in preventing restenosis after angioplasty or stenting. The AVID study investigates angiographic versus intravascular ultrasound directed stent placement in preventing restenosis. Intravascular brahcytherapy is also being studied using a novel delivery device with a Beta particle emitting source. New pharmaceuticals to prevent restenosis are also being tested.

Education/Certification

 

M.D., New York University School of Medicine – 1986
Resident, Beth Israel Hospital – 1986-89
Clinical Fellow, Yale-New Haven Hospital – 1989-91
Research Fellow, Yale-New Haven Hospital – 1991-1992
Fellow, Yale-New Haven Hospital – 1992-1993

 

Research and Professional Experience

 

University of Rochester School of Medicine and Dentistry, Assistant Professor of Medicine/Cardiology – 1993-2000
University of Rochester School of Medicine and Dentistry, Associate Professor of Medicine/Cardiology – 2000-Present

 

References

 

  • Azrin MA, Ling FS, Chen QC, Pawasne A, Migliaccio FG, Homer R, Todd M, Ezekowitz MD: Preparation, characterization, and evaluation of a monoclonal antibody against the rabbit platelet glycoprotein IIb/IIIa in an experimental angioplasty model. Circulation Research 1994;75:268-277.
  • Stuver TP, Ling FS: The "Furrowing Effect": guidewire induced "directional" lesion ablation in rotational atherectomy of angulated coronary artery disease. Catheterization & Cardiovascular Diagnosis1996; 39:385-395.
  • Pomerantz RM, Ling FS: Distortion of Palmaz-Schatz stent geometry following sidebranch balloon dilation through the stent in a rabbit model. Catheterization & Cardiovascular Diagnosis 1997; 40:422-426.

Contact

Dr. Frederick S. Ling
Paul N. Yu Heart Center
Strong Memorial Hospital
601 Elmwood Ave.
Ambulatory Center - Ground Floor
Rochester, NY 14642
Phone: 1-866-HEART-03



   
         
   

contact us | urmc | stronghealth | privacy